NCT00369408View on ClinicalTrials.gov

Targeted Naltrexone for Problem Drinkers

PHASE4CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2007

Study Completion Date

March 31, 2008

Conditions
AlcoholismAlcohol DrinkingAlcohol Dependence
Interventions
DRUG

Naltrexone

naltrexone (50 mg orally) for 12-week treatment period; 3 and 6 months post-treatment follow-up

DRUG

placebo

placebo for 12-week treatment period; 3 and 6 months post-treatment follow-up

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

UConn Health

OTHER

NCT00369408 - Targeted Naltrexone for Problem Drinkers | Biotech Hunter | Biotech Hunter